Work

393 A phase II study of OSI-774 given in combination with carboplatin in patients with recurrent ovarian cancer (NCIC IND.149)

Year: 2004

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(04)80400-2

Authors: H. Hirte, K. Swenerton, A. Oza, S. Ellard, M. Plante, R. Grimshaw, M. Carey, L. Seymour, B. Fisher, W. Walsh

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2045476991

Cites:

Cited by:

Related to: 10